Researchmoz added Most up-to-date research on "Global Organ Transplant Immunosuppressant Market Rising To Grow At A CAGR Of 3.81% Over The Period 2017 - 2021 With Novartis, Astellas Pharma and Pfizer" to its huge collection of research reports.
An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.
Technavios analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Novartis,
Astellas Pharma,
Pfizer,
Sanofi,
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1217095
Other prominent vendors
AbbVie
Bristol-Myers Squibb
F. Hoffmann-La Roche
Market driver
Increased incidence of organ failure
For a full, detailed list, view our report
Market challenge
Insufficient organ supply
For a full, detailed list, view our report
Market trend
Growing trend of medical tourism
For a full, detailed list, view our report
Browse TOC @ https://www.researchmoz.us/global-organ-transplant-immunosuppressant-market-2017-2021-report.html/toc
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.
Technavios analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Novartis,
Astellas Pharma,
Pfizer,
Sanofi,
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1217095
Other prominent vendors
AbbVie
Bristol-Myers Squibb
F. Hoffmann-La Roche
Market driver
Increased incidence of organ failure
For a full, detailed list, view our report
Market challenge
Insufficient organ supply
For a full, detailed list, view our report
Market trend
Growing trend of medical tourism
For a full, detailed list, view our report
Browse TOC @ https://www.researchmoz.us/global-organ-transplant-immunosuppressant-market-2017-2021-report.html/toc
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment